Why the study?
Does the presence of the d allele of the alpha(2A)-adrenoceptor gene associate with alterations in blood pressure, lipid, and carbohydrate metabolism in hypertensive patients?
Does the presence of the d allele of the alpha(2A)-adrenoceptor gene associate with alterations in blood pressure, lipid, and carbohydrate metabolism in hypertensive patients?
Answers are grounded in this paper and cite their sources.
The alpha(2A)-adrenoceptor gene polymorphism is associated with favorable differences in lipid and glucose metabolism, but not blood pressure, in hypertensive patients.
BACKGROUND: The aim of this study was to test an association between alleles of the alpha(2A)-adrenoceptor gene with hereditary hypertension and with alterations of lipid and carbohydrate metabolism. METHODS: Genomic DNA was isolated from 147 hypertensive patients and digested with DraI. Genotypes at the alpha(2A)-adrenoceptor were identified by restriction fragment length polymorphism. Genotype at each locus was related to blood pressure, family history of hypertension and various clinical chemistry parameters. RESULTS: The alpha(2A)-adrenoceptor polymorphism was not significantly associated with blood pressure or a family history of hypertension. Patients with the d allele of the alpha(2A)-adrenoceptor had significantly lower HbA(1) (5.6 vs 6.2%, P=0.0344) and HbA(1c) (3.4 vs 3.9%, P=0.0237) and total cholesterol (212 vs 229 mg/dl, P=0.0333) than those without. Similar trends, which failed to reach statistical significance, were seen for glucose, triglycerides and LDL cholesterol. CONCLUSIONS: We propose that alleles at the alpha(2A)-adrenoceptor locus might contribute to interindividual differences in the regulation of human lipid and glucose metabolism.
No takes yet. Share an insight, caveat, or question.
Michel et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: